Read Post Market Analysis published at 4 pm everday. click here
  1. home
  2. Company
  3. Glenmark
  4. Financials
Option chain For GLENMARK format_line_spacing
Max Pain For GLENMARK trending_up
Put-Call ratio For GLENMARK exposure
info_outline


Pivot Points
08 Jul 2020 03:33 PM IST
Name S3 S2 S1 Pivot Points R1 R2 R3
Fibonacci 407.50 412.08 414.92 419.50 424.08 426.92 431.50
Bollinger band (1,2) - 428.60 433.30 433.30 433.30 438.00 -


Technical Indicator
Name Value
Adx(14) 28.02
Rsi(14) 28.02
Stoch Rsi(14) 0.11
MACD(12,26) 13.26
Williams %R -84.09
ROC -6.28
Moving Averages
Period Simple Exponential
MA 9 439.29 432.59
MA 20 433.30 427.15
MA 50 385.35 391.10
MA 100 327.52 360.45
MA 200 328.42 353.48
Related News

US charges generic drug firm Glenmark with price-fixing

update 01 Jul 09:52 AM

Glenmark allegedly conspired with pharmaceutical maker Apotex Corp and other generic drug companies to increase the prices of cholesterol medication pravastatin and other generic drugs, the department said.

Brokerages’ views mixed on Glenmark Pharma

update 01 Jul 07:37 AM

Shares of Glenmark declined 3.7 per cent to close at Rs 450 on Tuesday.

Glenmark Pharma falls 5% on CLSA downgrade after Q4 earnings

update 30 Jun 03:30 PM

Glenmark reported 36 percent year-on-year increase in Q4FY20 profit at Rs 220 crore and 8 percent growth in revenue at Rs 2,764 crore during the quarter compared to year-ago.

Cipla and Glenmark top picks in the pharma space: Deven R Choksey

update 30 Jun 12:30 PM

‘Fortunately with market volatility, there are good opportunities to enter at low prices’

Neutral on Glenmark Pharma, target price Rs 430: Motilal Oswal

update 30 Jun 11:35 AM

The brokerage values Glenmark Pharma on a 13 times 12 month forward earnings basis to arrive at a price target of Rs 430.

Trending stocks: Glenmark Pharma shares rise nearly 2%

update 29 Jun 10:01 AM

A total of 423,479 shares changed hands on the counter till 10:03AM (IST).

Glenmark Pharma Q4 net profit jumps 36% to Rs 220 crore

update 26 Jun 10:41 PM

The company's consolidated revenue for the quarter rose 7.96 per cent to Rs 2,767.48 crore as against Rs 2,563.47 crore a year ago, Glenmark Pharmaceuticals said in a regulatory filing.

Glenmark Pharma Q4 results: Net profit jumps 36% to Rs 220 crore

update 26 Jun 10:26 PM

The Mumbai-based drug firm had reported a net profit of Rs 161.66 crore for the corresponding period of 2018-19.

HUL completes acquisition of female hygiene brand VWash from Glenmark

update 26 Jun 11:00 AM

The acquisition was announced in March and was subject to certain closing conditions, which have now been fulfilled, the FMCG firm said in a filing to BSE.

HUL completes acquisition of female hygiene brand VWash from Glenmark

update 26 Jun 10:55 AM

HUL has acquired intellectual property rights including trademarks, design and knowhow related to the VWash brand worldwide, the company said.
Indices



Open Zerodha account launch

( ₹ 20 / Trade )